| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ? |
| Routes | s.c. injection only, premedication with H1 and H2 antihistamines and beta-receptor agonists for bronchodilation |
| Pharmacokinetic data | |
| Half-life | 2.5 h |
| Excretion | renal: 90% |
| Identifiers | |
| CAS number | 163545-26-4 |
| ATC code | L03AA12 |
| UNII | PYB4Q6JG41 |
| KEGG | D02937 |
| Chemical data | |
| Formula | ? |
| |
|
Ancestim is a recombinant methionyl human stem cell factor, commonly known by the name StemGen.
It is a 166 amino acid protein produced by E. coli bacteria into which a gene has been inserted for soluble human stem cell factor.[1] It has a monomeric molecular weight of approximately 18,500 daltons and normally exists as a noncovalently associated dimer. The protein has an amino acid sequence that is identical to the natural sequence predicted from human DNA sequence analysis, except for the addition of an N-terminal methionine retained after expression in E. coli. Because Ancestim is produced in E. coli, it is nonglycosylated. Ancestim is supplied as a sterile, white, preservative-free, lyophilised powder for reconstitution and administration as a subcutaneous (SC) injection.
|
|||||||||||||||||||||||||||||
| This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)